In Vitro Antimalarial Activity of Chalcones and Their Derivatives

Rongshi Li, George L. Kenyon, Fred E. Cohen, Xiaowu Chen, Baoqing Gong, Jose N. Dominguez, Eugene Davidson, Gary Kurzban, Robert E. Miller, Edwin O. Nuzum, Philip J. Rosenthal, James H. McKerrow

Research output: Contribution to journalArticle

364 Citations (Scopus)

Abstract

A series of chalcones and their derivatives have been synthesized and identified as novel potential antimalarials using both molecular modeling and in vitro testing against the intact parasite. A large number of chalcones and their derivatives were prepared using one-step Claisen-Schmidt condensations of aldehydes with methyl ketones. These condensates were screened in vitro against both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum and shown to be active at concentrations in the nanomolar range. The most active chalcone derivative, 1-(2,5-dichlorophenyl)-3-(4-quinolinyl)-2-propen-1-one (7), had an IC50 value of 200 nM against both a chloroquine-resistant strain (W2) and a chloroquine-sensitive strain (D6). The resistance indexes for all compounds were substantially lower than for chloroquine, suggesting that this series will be active against chloroquine-resistant malaria. Structure-activity relationships (SAR) of the chalcones in the context of a homology-based model structure of the malaria trophozoite cysteine protease, the most likely target enzyme, are presented.

Original languageEnglish (US)
Pages (from-to)5031-5037
Number of pages7
JournalJournal of Medicinal Chemistry
Volume38
Issue number26
DOIs
StatePublished - Dec 1 1995

Fingerprint

Chalcones
Chloroquine
Antimalarials
Malaria
Chalcone
Trophozoites
Cysteine Proteases
Plasmodium falciparum
Structure-Activity Relationship
Ketones
Aldehydes
Inhibitory Concentration 50
In Vitro Techniques
Parasites
Enzymes

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Li, R., Kenyon, G. L., Cohen, F. E., Chen, X., Gong, B., Dominguez, J. N., ... McKerrow, J. H. (1995). In Vitro Antimalarial Activity of Chalcones and Their Derivatives. Journal of Medicinal Chemistry, 38(26), 5031-5037. https://doi.org/10.1021/jm00026a010

In Vitro Antimalarial Activity of Chalcones and Their Derivatives. / Li, Rongshi; Kenyon, George L.; Cohen, Fred E.; Chen, Xiaowu; Gong, Baoqing; Dominguez, Jose N.; Davidson, Eugene; Kurzban, Gary; Miller, Robert E.; Nuzum, Edwin O.; Rosenthal, Philip J.; McKerrow, James H.

In: Journal of Medicinal Chemistry, Vol. 38, No. 26, 01.12.1995, p. 5031-5037.

Research output: Contribution to journalArticle

Li, R, Kenyon, GL, Cohen, FE, Chen, X, Gong, B, Dominguez, JN, Davidson, E, Kurzban, G, Miller, RE, Nuzum, EO, Rosenthal, PJ & McKerrow, JH 1995, 'In Vitro Antimalarial Activity of Chalcones and Their Derivatives', Journal of Medicinal Chemistry, vol. 38, no. 26, pp. 5031-5037. https://doi.org/10.1021/jm00026a010
Li R, Kenyon GL, Cohen FE, Chen X, Gong B, Dominguez JN et al. In Vitro Antimalarial Activity of Chalcones and Their Derivatives. Journal of Medicinal Chemistry. 1995 Dec 1;38(26):5031-5037. https://doi.org/10.1021/jm00026a010
Li, Rongshi ; Kenyon, George L. ; Cohen, Fred E. ; Chen, Xiaowu ; Gong, Baoqing ; Dominguez, Jose N. ; Davidson, Eugene ; Kurzban, Gary ; Miller, Robert E. ; Nuzum, Edwin O. ; Rosenthal, Philip J. ; McKerrow, James H. / In Vitro Antimalarial Activity of Chalcones and Their Derivatives. In: Journal of Medicinal Chemistry. 1995 ; Vol. 38, No. 26. pp. 5031-5037.
@article{d7b7b61a66554b32a76e55646f86918e,
title = "In Vitro Antimalarial Activity of Chalcones and Their Derivatives",
abstract = "A series of chalcones and their derivatives have been synthesized and identified as novel potential antimalarials using both molecular modeling and in vitro testing against the intact parasite. A large number of chalcones and their derivatives were prepared using one-step Claisen-Schmidt condensations of aldehydes with methyl ketones. These condensates were screened in vitro against both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum and shown to be active at concentrations in the nanomolar range. The most active chalcone derivative, 1-(2,5-dichlorophenyl)-3-(4-quinolinyl)-2-propen-1-one (7), had an IC50 value of 200 nM against both a chloroquine-resistant strain (W2) and a chloroquine-sensitive strain (D6). The resistance indexes for all compounds were substantially lower than for chloroquine, suggesting that this series will be active against chloroquine-resistant malaria. Structure-activity relationships (SAR) of the chalcones in the context of a homology-based model structure of the malaria trophozoite cysteine protease, the most likely target enzyme, are presented.",
author = "Rongshi Li and Kenyon, {George L.} and Cohen, {Fred E.} and Xiaowu Chen and Baoqing Gong and Dominguez, {Jose N.} and Eugene Davidson and Gary Kurzban and Miller, {Robert E.} and Nuzum, {Edwin O.} and Rosenthal, {Philip J.} and McKerrow, {James H.}",
year = "1995",
month = "12",
day = "1",
doi = "10.1021/jm00026a010",
language = "English (US)",
volume = "38",
pages = "5031--5037",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "26",

}

TY - JOUR

T1 - In Vitro Antimalarial Activity of Chalcones and Their Derivatives

AU - Li, Rongshi

AU - Kenyon, George L.

AU - Cohen, Fred E.

AU - Chen, Xiaowu

AU - Gong, Baoqing

AU - Dominguez, Jose N.

AU - Davidson, Eugene

AU - Kurzban, Gary

AU - Miller, Robert E.

AU - Nuzum, Edwin O.

AU - Rosenthal, Philip J.

AU - McKerrow, James H.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - A series of chalcones and their derivatives have been synthesized and identified as novel potential antimalarials using both molecular modeling and in vitro testing against the intact parasite. A large number of chalcones and their derivatives were prepared using one-step Claisen-Schmidt condensations of aldehydes with methyl ketones. These condensates were screened in vitro against both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum and shown to be active at concentrations in the nanomolar range. The most active chalcone derivative, 1-(2,5-dichlorophenyl)-3-(4-quinolinyl)-2-propen-1-one (7), had an IC50 value of 200 nM against both a chloroquine-resistant strain (W2) and a chloroquine-sensitive strain (D6). The resistance indexes for all compounds were substantially lower than for chloroquine, suggesting that this series will be active against chloroquine-resistant malaria. Structure-activity relationships (SAR) of the chalcones in the context of a homology-based model structure of the malaria trophozoite cysteine protease, the most likely target enzyme, are presented.

AB - A series of chalcones and their derivatives have been synthesized and identified as novel potential antimalarials using both molecular modeling and in vitro testing against the intact parasite. A large number of chalcones and their derivatives were prepared using one-step Claisen-Schmidt condensations of aldehydes with methyl ketones. These condensates were screened in vitro against both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum and shown to be active at concentrations in the nanomolar range. The most active chalcone derivative, 1-(2,5-dichlorophenyl)-3-(4-quinolinyl)-2-propen-1-one (7), had an IC50 value of 200 nM against both a chloroquine-resistant strain (W2) and a chloroquine-sensitive strain (D6). The resistance indexes for all compounds were substantially lower than for chloroquine, suggesting that this series will be active against chloroquine-resistant malaria. Structure-activity relationships (SAR) of the chalcones in the context of a homology-based model structure of the malaria trophozoite cysteine protease, the most likely target enzyme, are presented.

UR - http://www.scopus.com/inward/record.url?scp=0029594562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029594562&partnerID=8YFLogxK

U2 - 10.1021/jm00026a010

DO - 10.1021/jm00026a010

M3 - Article

C2 - 8544179

AN - SCOPUS:0029594562

VL - 38

SP - 5031

EP - 5037

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 26

ER -